Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2023-01-20
2024-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Training and Practice Effects in Mild Cognitive Impairment
NCT02301546
Evaluating a Digital Memory Notebook App to Improve Functional Independence
NCT03453554
Everyday Memory Intervention
NCT04088136
Protocol of Virtual Interactive Memory-Training Program
NCT02462135
Efficacy of Cognitive Training in Subjective Memory Impairment
NCT02555774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants who pass initial phone screening criteria will participate in a 2-3 hour neurocognitive assessment over zoom to establish baseline cognition, prior to beginning the intervention. Participants will also complete questionnaires and a real-world measure assessing daily functioning. After the initial assessment is complete, participants will be given one-month to learn to use the EMMA app by completing the self-paced intervention via the adaptive, web-based training platform, which includes six lessons. EMMA device-use will be captured throughout the study by the app itself.
A component of the self-paced, web-based intervention involves setting goals related to using the EMMA app. A clinician will monitor the training data and goals the T+C group participants make and conduct brief problem-solving and goal-refining sessions during the intervention weeks. These sessions are expected to be 10-15 minutes. To keep training on track, the T-only group will receive brief phone check-ins to monitor progression through the web-based intervention. Following training, there will no longer be any differences in the treatment of both groups, which will be monitored for an additional three months. Immediately following training and at the end of the 3 month monitoring period, all participants will complete the battery of questionnaires and answer a semi-structured phone interview. In addition, at the end of the 3 month follow-up, all participants will again complete the neurocognitive assessment and real-world measure of daily functioning.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brief Clinician Motivational Support
Participants will learn to use the EMMA app through a personalized web-based training platform with brief weekly motivational support from a clinician.
Personalized Web-based training for EMMA app
Participants will complete six sessions of training to support uptake and habit formation of EMMA app use with a personalized web-based training platform.
Motivational Interviewing: Clinician Support
Participants will receive weekly brief check-ins with clinicians to motivate and support the problem-solving and habit formation aspects of the web-based training.
Technology Support Only
Participants will learn to use the EMMA app through a personalized web-based training platform with technical support and reminders as needed.
Personalized Web-based training for EMMA app
Participants will complete six sessions of training to support uptake and habit formation of EMMA app use with a personalized web-based training platform.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalized Web-based training for EMMA app
Participants will complete six sessions of training to support uptake and habit formation of EMMA app use with a personalized web-based training platform.
Motivational Interviewing: Clinician Support
Participants will receive weekly brief check-ins with clinicians to motivate and support the problem-solving and habit formation aspects of the web-based training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-reporting subjective cognitive complaints (screening questions)
* Must be able to read and speak English
Exclusion Criteria
* Have a known medical, neurological or psychiatric diagnosis that explains current cognitive complaints (e.g., stroke)
* Cannot complete remote study protocol due to severe vision or hearing difficulties
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Washington State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maureen-Schmitter-Edgecombe
Regents Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maureen Schmitter-Edgecombe, PhD
Role: PRINCIPAL_INVESTIGATOR
Washington State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington State University - Pullman; Study Remote
Pullman, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AZ190055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.